Robert W. Duggan, Director, 10% Owner at Pulse Biosciences, Inc. (PLSE), bought 220,267 shares at $9.21 ($2.1M) on 2023-11-29, disclosed to the SEC on 2023-12-01.
Open-market purchase of $2.1M PLSE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.95 | 1,667 | $10K | 0.5% |
| 2 | $9.21 | 60,000 | $553K | 26.8% |
| 3 | $9.44 | 158,600 | $1.5M | 72.7% |
| Total | $9.35 avg | 220,267 | $2.1M | 100% |
| Filing → |
| PLSE | BUY | 2026-05-11 | $13.0M | — | Filing → |
| SMMT | BUY | 2025-10-23 | $1000K | — | Filing → |
| PLSE | BUY | 2025-09-12 | $5.4M | — | Filing → |